Integrated machine learning and single-cell analysis reveal the prognostic and therapeutic potential of SUMOylation-related genes in ovarian cancer.

Front Immunol · 2025 · PMC12174102 · PMID 40534859

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

However, we found no significant differences at the endpoint and the tumor burden in the SUMOylation inhibition group showed an increasing trend compared to the NC group ( Figures 1D, E ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.